Radiologic images of an aggressive implant-associated fibromatosis of the breast and chest wall: case report and review of the literature

Alanis, Lourdes; Roth, Robyn; Lerman, Nati; Barroeta, Julieta E.; Germaine, Pauline

doi:10.1016/j.radcr.2017.04.012

Cited by 15 publications

(30 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several cases have been reported in the literature which details the development of fibromatosis after breast surgery, including cosmetic implants . The diagnosis of this disease may be especially difficult in the augmented patient, and it is often associated with the capsule around the implant . The development of fibromatosis after radiation to the chest has been observed in our own data.…”

Section: Resultssupporting

confidence: 65%

“…Fibromatosis arising within the breast parenchyma accounts for <0.3% of all breast tumors . It is more common in young, premenopausal women . When fibromatosis of the breast is discussed in the literature, it is often presented as case reports.…”

Section: Resultsmentioning

confidence: 99%

“…Mammographic findings mimic breast carcinoma and are often indistinguishable; however, calcifications are an unusual clinical finding with this entity. Additionally, ultrasound findings may show a well‐circumscribed mass that resembles a fibroadenoma, which can result in inadequate resections, which is an important pitfall to avoid . Pain is often a finding in advanced disease when the chest wall is involved.…”

Section: Resultsmentioning

confidence: 99%

“…Radiation has been shown to decrease local recurrence in cases with positive margins, with up to a 25% reduction in local recurrence (from 54% to 24%) and should be strongly considered in cases where further surgical resection is not feasible . Treatment with systemic chemotherapy has often been met with failure and disease progression . Therefore, surgical excision should be considered the first line and most efficacious treatment for breast fibromatosis.…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Breast fibromatosis: Making the case for primary vs secondary subtypes

et al. 2019

View full text Add to dashboard Cite

Fibromatosis of the breast is a rare condition that can be locally aggressive. The mainstay of treatment remains wide local excision, with varied adjuvant therapy as needed. The authors describe their experience in the treatment of a series of patients and propose the classification of primary and secondary breast fibromatosis. A single‐institution retrospective analysis of patients treated for breast fibromatosis from 2003 to 2017 was completed. Demographic data, pertinent past medical history, and treatment modalities were reviewed. Primary breast fibromatosis was defined as arising in the absence of previous surgery or radiation therapy to the ipsilateral breast. Secondary breast fibromatosis was defined as arising in the setting of previous surgery or radiation therapy to the ipsilateral breast. A total of 16 patients were included with the median age 40 (28‐64) years. The average size of the lesion was 6.37 cm (range of 1.5‐15 cm). Mean follow‐up time was 65 months. Surgical excision was completed in 14 patients, with two recurrences. There were no recurrences in patients with surgical margins >1 cm. Two patients were treated nonsurgically. There were seven patients with primary fibromatosis of the breast and nine patients with secondary fibromatosis of the breast. Fibromatosis of the breast is difficult to diagnose prior to surgical excision. We advocate for the multi‐disciplinary treatment of this disease process with an aggressive surgical approach to achieve margins >1 cm.

show abstract

Section: Resultssupporting

confidence: 65%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Breast fibromatosis: Making the case for primary vs secondary subtypes

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Olguların dörtte üçünde β-katenin ekspresyonu izlenir (12). S-100, CD34, sitokeratin ve CD117 ile ekspresyon izlenmez (14).…”

Section: Discussionunclassified

Schwannoma of breast: a case report

Baş¹,

Demirci²,

Özkan³

et al. 2018

JCurrPath

View full text Add to dashboard Cite

Tel: 0 541 911 81 12 (J Curr Pathol. 2018;1:16-20.) ÖZET Amaç: Schwannoma myelin üreten Schwan hücrelerinden köken alan benign, kapsüllü, periferik sinir kılıfı tümörüdür. Schwannoma meme dokusunda çok nadir görülür ve izlenen çoğu olguda meme derisi ve subkutanöz yerleşimlidir. Biz burada son derece nadir lokalizasyonda izlenen bu tümöral lezyonu yaratacağı ayrıcı tanı karmaşasını da göz önüne alarak sunduk.Olgu: 26 yaşında kadın hasta sol memede 14 yıldır mevcut olan ve zaman zaman ağrı yapan kitle nedeniyle lumpektomi operasyonu geçirmiş ve Schwannoma tanısı almıştır. Sonuç:Meme yerleşimli Schwannoma oldukça nadir görülen ve memedeki diğer iğsi hücreli neoplazilerle ayrıcı tanı karmaşası yaratan bir lezyondur.Anahtar Sözcükler: Schwannoma, Meme, İğsi hücreli lezyonlar ABSTRACT Aim: Schwannoma is a benign, encapsulated, biphasic peripheral nerve sheath tumor originating in Schwan cells producing myelin. Schwannoma is very rare in the breast, and most cases are present in breast skin and subcutaneous tissue. Here we present Schwannoma of breast and discuss the differential diagnosis. Case:A 26-year-old woman had lumpectomy due to a painful mass that had been present in her left breast for 14 years and was diagnosed with Schwannoma. Conclusion:Schwannoma of breast is a rare lesion that needs to be distinguished from other spindle-cell neoplasms.

show abstract

Ultrasound characteristics of breast fibromatosis mimicking carcinoma

Su,

Huang,

et al. 2023

J of Clinical Ultrasound

View full text Add to dashboard Cite

PurposeTo explore the value of ultrasound (US) characteristics in diagnosing breast fibromatosis (BF) and evaluate their differences from breast carcinoma.MethodsA total of 121 patients with BF (n = 24, 29 lesions) or invasive ductal carcinoma (IDC) (n = 97, 102 lesions) of the breast were included. Their clinical and US findings were recorded and analyzed.ResultsThe mean age of BF was younger than that of IDC (28.75 ± 5.55 vs. 50.19 ± 9.87, p < 0.001). The mean size of the BF was smaller than that of IDC (2.09 ± 0.91 vs. 2.71 ± 1.20, p = 0.011). Compared to IDC, BF had more frequency of posterior echo attenuation (p < 0.001), less frequency of peripheral hyperechoic halo (p = 0.002), calcification (p = 0.001), US reported axillary lymph node positive (p = 0.025), and grade 2–3 vascularity (p < 0.001). The Breast Imaging Reporting and Data System categorized BF at a lower level than IDC (p < 0.001). After adjusting for age, the peripheral hyperechoic halo, posterior echo feature, and vascularity could independently identify the differences between these two entities.ConclusionSome differences were observed between BF and IDC in terms of patient age, lesion size, and US characteristics.

show abstract

Radiologic images of an aggressive implant-associated fibromatosis of the breast and chest wall: case report and review of the literature

Cited by 15 publications

References 35 publications

Breast fibromatosis: Making the case for primary vs secondary subtypes

Breast fibromatosis: Making the case for primary vs secondary subtypes

Schwannoma of breast: a case report

Ultrasound characteristics of breast fibromatosis mimicking carcinoma

Contact Info

Product

Resources

About